The global Intramuscular Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Intramuscular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intramuscular Drug Delivery.

Report Scope

The Intramuscular Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intramuscular Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intramuscular Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Intramuscular Drug Delivery Market Report

Report Metric	Details
Report Name	Intramuscular Drug Delivery Market
CAGR	5%
Segment by Type	Drug Molecule Delivery Devices
Segment by Application	Infectious Disease Oncology Autoimmune Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals, Pfizer, Pharmajet, Teva Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intramuscular Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intramuscular Drug Delivery Market report?

Ans: The main players in the Intramuscular Drug Delivery Market are Antares Pharma, Eli Lily, Galaxo, HMD pharmaceuticals, Inovio Pharmaceuticals, Merck, Novartis, Pacira Pharmaceuticals, Pfizer, Pharmajet, Teva Pharmaceutical

What are the Application segmentation covered in the Intramuscular Drug Delivery Market report?

Ans: The Applications covered in the Intramuscular Drug Delivery Market report are Infectious Disease, Oncology, Autoimmune Diseases

What are the Type segmentation covered in the Intramuscular Drug Delivery Market report?

Ans: The Types covered in the Intramuscular Drug Delivery Market report are Drug Molecule, Delivery Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Intramuscular Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Drug Molecule

1.2.3 Delivery Devices

1.3 Market by Application

1.3.1 Global Intramuscular Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Infectious Disease

1.3.3 Oncology

1.3.4 Autoimmune Diseases

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Intramuscular Drug Delivery Market Perspective (2019-2030)

2.2 Intramuscular Drug Delivery Growth Trends by Region

2.2.1 Global Intramuscular Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Intramuscular Drug Delivery Historic Market Size by Region (2019-2024)

2.2.3 Intramuscular Drug Delivery Forecasted Market Size by Region (2025-2030)

2.3 Intramuscular Drug Delivery Market Dynamics

2.3.1 Intramuscular Drug Delivery Industry Trends

2.3.2 Intramuscular Drug Delivery Market Drivers

2.3.3 Intramuscular Drug Delivery Market Challenges

2.3.4 Intramuscular Drug Delivery Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Intramuscular Drug Delivery Players by Revenue

3.1.1 Global Top Intramuscular Drug Delivery Players by Revenue (2019-2024)

3.1.2 Global Intramuscular Drug Delivery Revenue Market Share by Players (2019-2024)

3.2 Global Intramuscular Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Intramuscular Drug Delivery Revenue

3.4 Global Intramuscular Drug Delivery Market Concentration Ratio

3.4.1 Global Intramuscular Drug Delivery Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Intramuscular Drug Delivery Revenue in 2023

3.5 Intramuscular Drug Delivery Key Players Head office and Area Served

3.6 Key Players Intramuscular Drug Delivery Product Solution and Service

3.7 Date of Enter into Intramuscular Drug Delivery Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Intramuscular Drug Delivery Breakdown Data by Type

4.1 Global Intramuscular Drug Delivery Historic Market Size by Type (2019-2024)

4.2 Global Intramuscular Drug Delivery Forecasted Market Size by Type (2025-2030)

5 Intramuscular Drug Delivery Breakdown Data by Application

5.1 Global Intramuscular Drug Delivery Historic Market Size by Application (2019-2024)

5.2 Global Intramuscular Drug Delivery Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Intramuscular Drug Delivery Market Size (2019-2030)

6.2 North America Intramuscular Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Intramuscular Drug Delivery Market Size by Country (2019-2024)

6.4 North America Intramuscular Drug Delivery Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Intramuscular Drug Delivery Market Size (2019-2030)

7.2 Europe Intramuscular Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Intramuscular Drug Delivery Market Size by Country (2019-2024)

7.4 Europe Intramuscular Drug Delivery Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Intramuscular Drug Delivery Market Size (2019-2030)

8.2 Asia-Pacific Intramuscular Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2019-2024)

8.4 Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Intramuscular Drug Delivery Market Size (2019-2030)

9.2 Latin America Intramuscular Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Intramuscular Drug Delivery Market Size by Country (2019-2024)

9.4 Latin America Intramuscular Drug Delivery Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Intramuscular Drug Delivery Market Size (2019-2030)

10.2 Middle East & Africa Intramuscular Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2019-2024)

10.4 Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Antares Pharma

11.1.1 Antares Pharma Company Detail

11.1.2 Antares Pharma Business Overview

11.1.3 Antares Pharma Intramuscular Drug Delivery Introduction

11.1.4 Antares Pharma Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.1.5 Antares Pharma Recent Development

11.2 Eli Lily

11.2.1 Eli Lily Company Detail

11.2.2 Eli Lily Business Overview

11.2.3 Eli Lily Intramuscular Drug Delivery Introduction

11.2.4 Eli Lily Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.2.5 Eli Lily Recent Development

11.3 Galaxo

11.3.1 Galaxo Company Detail

11.3.2 Galaxo Business Overview

11.3.3 Galaxo Intramuscular Drug Delivery Introduction

11.3.4 Galaxo Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.3.5 Galaxo Recent Development

11.4 HMD pharmaceuticals

11.4.1 HMD pharmaceuticals Company Detail

11.4.2 HMD pharmaceuticals Business Overview

11.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Introduction

11.4.4 HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.4.5 HMD pharmaceuticals Recent Development

11.5 Inovio Pharmaceuticals

11.5.1 Inovio Pharmaceuticals Company Detail

11.5.2 Inovio Pharmaceuticals Business Overview

11.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Introduction

11.5.4 Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.5.5 Inovio Pharmaceuticals Recent Development

11.6 Merck

11.6.1 Merck Company Detail

11.6.2 Merck Business Overview

11.6.3 Merck Intramuscular Drug Delivery Introduction

11.6.4 Merck Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.6.5 Merck Recent Development

11.7 Novartis

11.7.1 Novartis Company Detail

11.7.2 Novartis Business Overview

11.7.3 Novartis Intramuscular Drug Delivery Introduction

11.7.4 Novartis Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.7.5 Novartis Recent Development

11.8 Pacira Pharmaceuticals

11.8.1 Pacira Pharmaceuticals Company Detail

11.8.2 Pacira Pharmaceuticals Business Overview

11.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Introduction

11.8.4 Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.8.5 Pacira Pharmaceuticals Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Detail

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Intramuscular Drug Delivery Introduction

11.9.4 Pfizer Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.9.5 Pfizer Recent Development

11.10 Pharmajet

11.10.1 Pharmajet Company Detail

11.10.2 Pharmajet Business Overview

11.10.3 Pharmajet Intramuscular Drug Delivery Introduction

11.10.4 Pharmajet Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.10.5 Pharmajet Recent Development

11.11 Teva Pharmaceutical

11.11.1 Teva Pharmaceutical Company Detail

11.11.2 Teva Pharmaceutical Business Overview

11.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Introduction

11.11.4 Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2019-2024)

11.11.5 Teva Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Antares Pharma

Eli Lily

Galaxo

Inovio Pharmaceuticals

Merck

Novartis

Pacira Pharmaceuticals

List of Tables

Table 1. Global Intramuscular Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Drug Molecule

Table 3. Key Players of Delivery Devices

Table 4. Global Intramuscular Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Intramuscular Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Intramuscular Drug Delivery Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Intramuscular Drug Delivery Market Share by Region (2019-2024)

Table 8. Global Intramuscular Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Intramuscular Drug Delivery Market Share by Region (2025-2030)

Table 10. Intramuscular Drug Delivery Market Trends

Table 11. Intramuscular Drug Delivery Market Drivers

Table 12. Intramuscular Drug Delivery Market Challenges

Table 13. Intramuscular Drug Delivery Market Restraints

Table 14. Global Intramuscular Drug Delivery Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Intramuscular Drug Delivery Market Share by Players (2019-2024)

Table 16. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2023)

Table 17. Ranking of Global Top Intramuscular Drug Delivery Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Intramuscular Drug Delivery Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Intramuscular Drug Delivery Product Solution and Service

Table 21. Date of Enter into Intramuscular Drug Delivery Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Intramuscular Drug Delivery Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Intramuscular Drug Delivery Revenue Market Share by Type (2019-2024)

Table 25. Global Intramuscular Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Intramuscular Drug Delivery Revenue Market Share by Type (2025-2030)

Table 27. Global Intramuscular Drug Delivery Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Intramuscular Drug Delivery Revenue Market Share by Application (2019-2024)

Table 29. Global Intramuscular Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Intramuscular Drug Delivery Revenue Market Share by Application (2025-2030)

Table 31. North America Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Intramuscular Drug Delivery Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Intramuscular Drug Delivery Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Intramuscular Drug Delivery Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Intramuscular Drug Delivery Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Intramuscular Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Intramuscular Drug Delivery Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Intramuscular Drug Delivery Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Intramuscular Drug Delivery Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Intramuscular Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Intramuscular Drug Delivery Market Size by Country (2025-2030) & (US$ Million)

Table 46. Antares Pharma Company Detail

Table 47. Antares Pharma Business Overview

Table 48. Antares Pharma Intramuscular Drug Delivery Product

Table 49. Antares Pharma Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 50. Antares Pharma Recent Development

Table 51. Eli Lily Company Detail

Table 52. Eli Lily Business Overview

Table 53. Eli Lily Intramuscular Drug Delivery Product

Table 54. Eli Lily Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 55. Eli Lily Recent Development

Table 56. Galaxo Company Detail

Table 57. Galaxo Business Overview

Table 58. Galaxo Intramuscular Drug Delivery Product

Table 59. Galaxo Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 60. Galaxo Recent Development

Table 61. HMD pharmaceuticals Company Detail

Table 62. HMD pharmaceuticals Business Overview

Table 63. HMD pharmaceuticals Intramuscular Drug Delivery Product

Table 64. HMD pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 65. HMD pharmaceuticals Recent Development

Table 66. Inovio Pharmaceuticals Company Detail

Table 67. Inovio Pharmaceuticals Business Overview

Table 68. Inovio Pharmaceuticals Intramuscular Drug Delivery Product

Table 69. Inovio Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 70. Inovio Pharmaceuticals Recent Development

Table 71. Merck Company Detail

Table 72. Merck Business Overview

Table 73. Merck Intramuscular Drug Delivery Product

Table 74. Merck Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 75. Merck Recent Development

Table 76. Novartis Company Detail

Table 77. Novartis Business Overview

Table 78. Novartis Intramuscular Drug Delivery Product

Table 79. Novartis Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 80. Novartis Recent Development

Table 81. Pacira Pharmaceuticals Company Detail

Table 82. Pacira Pharmaceuticals Business Overview

Table 83. Pacira Pharmaceuticals Intramuscular Drug Delivery Product

Table 84. Pacira Pharmaceuticals Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 85. Pacira Pharmaceuticals Recent Development

Table 86. Pfizer Company Detail

Table 87. Pfizer Business Overview

Table 88. Pfizer Intramuscular Drug Delivery Product

Table 89. Pfizer Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 90. Pfizer Recent Development

Table 91. Pharmajet Company Detail

Table 92. Pharmajet Business Overview

Table 93. Pharmajet Intramuscular Drug Delivery Product

Table 94. Pharmajet Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 95. Pharmajet Recent Development

Table 96. Teva Pharmaceutical Company Detail

Table 97. Teva Pharmaceutical Business Overview

Table 98. Teva Pharmaceutical Intramuscular Drug Delivery Product

Table 99. Teva Pharmaceutical Revenue in Intramuscular Drug Delivery Business (2019-2024) & (US$ Million)

Table 100. Teva Pharmaceutical Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Intramuscular Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Intramuscular Drug Delivery Market Share by Type: 2023 VS 2030

Figure 3. Drug Molecule Features

Figure 4. Delivery Devices Features

Figure 5. Global Intramuscular Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Intramuscular Drug Delivery Market Share by Application: 2023 VS 2030

Figure 7. Infectious Disease Case Studies

Figure 8. Oncology Case Studies

Figure 9. Autoimmune Diseases Case Studies

Figure 10. Intramuscular Drug Delivery Report Years Considered

Figure 11. Global Intramuscular Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Intramuscular Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Intramuscular Drug Delivery Market Share by Region: 2023 VS 2030

Figure 14. Global Intramuscular Drug Delivery Market Share by Players in 2023

Figure 15. Global Top Intramuscular Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intramuscular Drug Delivery as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Intramuscular Drug Delivery Revenue in 2023

Figure 17. North America Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Intramuscular Drug Delivery Market Share by Country (2019-2030)

Figure 19. United States Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Intramuscular Drug Delivery Market Share by Country (2019-2030)

Figure 23. Germany Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Intramuscular Drug Delivery Market Share by Region (2019-2030)

Figure 31. China Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Intramuscular Drug Delivery Market Share by Country (2019-2030)

Figure 39. Mexico Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Intramuscular Drug Delivery Market Share by Country (2019-2030)

Figure 43. Turkey Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Intramuscular Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Antares Pharma Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 46. Eli Lily Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 47. Galaxo Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 48. HMD pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 49. Inovio Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 50. Merck Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 51. Novartis Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 52. Pacira Pharmaceuticals Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 53. Pfizer Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 54. Pharmajet Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 55. Teva Pharmaceutical Revenue Growth Rate in Intramuscular Drug Delivery Business (2019-2024)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions